Considering people at clinical high risk for psychosis with normodopaminergia: Clinical case of progression to treatment-resistant schizophrenia in three years

Asian J Psychiatr. 2024 May:95:104006. doi: 10.1016/j.ajp.2024.104006. Epub 2024 Mar 11.

Authors

Tae Young Lee¹, Nahrie S Kim², Aram Im²

Affiliations

¹ Department of Psychiatry, Chonnam National University Medical School, Gwangju, South Korea. Electronic address: [email protected].
² Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, South Korea.

PMID: 38513511
DOI: 10.1016/j.ajp.2024.104006

No abstract available

Publication types

Letter
Case Reports

MeSH terms

Adult
Antipsychotic Agents / therapeutic use
Disease Progression*
Female
Humans
Psychotic Disorders / drug therapy
Schizophrenia / drug therapy
Schizophrenia, Treatment-Resistant / drug therapy